Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

Published on 21 Nov 2024 on Zacks · via Yahoo Finance

GKOS stock gains from strong product demand, international expansion and pipeline progress, which...

Read the rest of the article

Start tracking your investments with Statfolio

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 9 Jan 2025

Shares of Glaukos Corporation GKOS scaled a new 52-week high of $155.76 on Jan. 6, before closing...

Zacks · via Yahoo Finance 7 Jan 2025

Glaukos Corporation GKOS recently announced that it has submitted its New Drug Application (NDA) ...

Zacks · via Yahoo Finance 24 Dec 2024

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 11 Dec 2024

GKOS stock gains from strong product demand, international expansion and pipeline progress, which...

Zacks · via Yahoo Finance 21 Nov 2024

Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from...

Benzinga 3 May 2024

Glaukos Corporation GKOS reported first-quarter 2024 adjusted loss of 70 cents per share, which i...

Zacks via Yahoo Finance 3 May 2024

On Thursday, Glaukos Corporation (NYSE:GKOS) received an updated stock price target from Needham,...

Investing.com 3 May 2024

The earnings season for the Medical sector (one of the 16 broad Zacks sectors within the Zacks In...

Zacks via Yahoo Finance 1 May 2024

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 15 Apr 2024